Bracco Sustainability Profile
Bracco Imaging S.p.A., commonly known as Bracco, is a leading global player in the medical imaging industry, headquartered in Italy. Founded in 1927, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. Bracco is renowned for its innovative contrast agents and advanced imaging solutions, which enhance diagnostic accuracy and patient care. With a commitment to research and development, Bracco has achieved significant milestones, including the introduction of groundbreaking products that set industry standards. Their core offerings, such as ultrasound contrast agents and MRI contrast media, are distinguished by their safety profiles and efficacy. As a trusted partner in healthcare, Bracco continues to solidify its market position through strategic collaborations and a focus on quality, making it a preferred choice among healthcare professionals worldwide.
DitchCarbon Score
How does Bracco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bracco's score of 33 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bracco's reported carbon emissions
In 2024, Bracco reported total carbon emissions of approximately 64,216,210 kg CO2e for Scope 1 and about 33,812,350 kg CO2e for Scope 2, reflecting their ongoing commitment to monitoring and managing their carbon footprint. The previous year, 2023, saw similar figures with Scope 1 emissions at around 62,781,859 kg CO2e and Scope 2 emissions at about 35,410,031 kg CO2e. Bracco's emissions data indicates a focus on reducing their environmental impact, although specific reduction targets or initiatives have not been disclosed. The company has not reported any Scope 3 emissions, which typically encompass indirect emissions from the supply chain and product use. The emissions data is not cascaded from any parent organization, indicating that Bracco S.p.A. independently manages its sustainability reporting. As a company headquartered in Italy, Bracco is positioned within the global healthcare sector, where climate commitments are increasingly critical for operational sustainability and corporate responsibility. Overall, while Bracco has made strides in tracking its emissions, further transparency regarding reduction targets and initiatives would enhance its climate commitment profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 49,469,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 41,475,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
How Carbon Intensive is Bracco's Industry?
How Carbon Intensive is Bracco's Location?
Bracco's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bracco has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
